Our Team’s Paper on RAG in Medicine Is Now Among the Most Read & Most Cited in Digital Health Journal

At Hekma Smart Solutions, we are proud to announce that, according to the Digital Health Journal website, a paper authored by our research team, has been recognized as one of the most read and most cited articles in Digital Health (from Sage Journals).

Hekma Smart Solutions is the representative of Novarea Inc. in Oman and other GCC region states. We have developed Healthora as a modern and comprehensive digital health platform. We have also published several other research articles in the field of AI applications in medical sciences in prestigious international journals.

What the Paper Covers

This review focuses on Retrieval-Augmented Generation (RAG)—a technique that significantly improves the reliability of large language models (LLMs) in medical settings. Instead of relying solely on a model’s internal knowledge (which can be outdated or incorrect), RAG retrieves relevant, up-to-date information from trusted external sources and standard medical references before generating an answer.

The paper identifies three key advantages of RAG for medical AI:

  • Reduced hallucination – Grounding responses in retrieved documents improves factual accuracy.
  • Up-to-date knowledge – The external knowledge base can be updated without retraining the model.
  • Transparency – Answers can be traced back to their source documents.

It also highlights three major clinical applications where RAG is already showing promise:

  1. Clinical decision support – Interpreting guidelines at the point of care.
  2. Diagnostic assistance – Improving accuracy by retrieving relevant criteria and case data.
  3. Clinical trial screening – Automating patient-trial matching efficiently.

Our team is committed to building safe, transparent, and effective AI for healthcare. This paper reflects the research foundation that guides our development. The recognition it has received tells us we are focused on the right problems with the right solutions.

We thank the Digital Health editorial team, the peer reviewers, and everyone who has read and cited our work.

Hekma Smart Solutions has been awarded a Research Grant on AI in Childhood Asthma from Oman National University

Hekma Smart Solutions is proud to announce that we have been awarded a research grant from Oman National University of Science and Technology to lead an innovative project on Machine Learning application in Childhood Asthma Risk Prediction.
Dr. Prashanth Gowda is the Principal Investigator of this project and the team leader. He is also the Associate Professor and Head of the Pediatrics Department at the College of Medicine, National University of Science and Technology.
This achievement reflects months of dedicated work by our research team and the trust that Oman National University has placed in our scientific vision and technical expertise.

Why This Project Matters
Asthma is one of the most common chronic respiratory diseases worldwide, affecting over 339 million people. In children, the burden is especially heavy—on healthcare systems, families, and the children themselves.
Recent studies estimate the global prevalence of childhood asthma at approximately 10.2%, with most cases beginning in the first five years of life. In Oman, asthma remains a major public health concern.
Unfortunately:
• There is no cure for asthma.
• Early prediction tools are very limited and rarely usable in clinical settings.
• Children under 10 years carry the highest risk but have the fewest preventive tools available.
This is where machine learning can create a real transformation.

What Is the Goal of This Project?
We aim to design and validate a machine learning–based application that predicts the risk of developing asthma in children under 10 years by integrating clinical, family, environmental, and even wearable data.
Key features of this application:
• Early asthma risk prediction (by age 4)
• Uses longitudinal data (from birth to age 4)
• Model transparency with SHAP (interpretable for clinicians)
• Fairness assessment across sex, ancestry, and socioeconomic groups
• Ready for deployment in primary care and clinical settings

What Methods Are We Using?
Our team will use state of the art machine learning algorithms, including:
• XGBoost
• TabNet
• Support Vector Machine (SVM)
• Deep Neural Networks
Data will be sourced from validated birth cohorts and electronic health records (EHRs). For handling missing data, we will apply Multiple Imputation by Chained Equations (MICE).
Beyond accuracy (AUC), we will assess real clinical utility using Decision Curve Analysis (DCA).

Key Research Questions

  1. Can machine learning models using data up to age 4 accurately predict asthma risk between ages 4 and 8 years?
  2. Which early-life determinants (e.g., wheeze, maternal asthma, infection, antibiotics, atopy) best predict asthma risk?
  3. Which machine learning algorithm performs best in terms of accuracy, calibration, and clinical utility?
  4. Is the final model fair and interpretable across subgroups (sex, ancestry, socioeconomic status)?

Expected Outcomes and Impact
• Early identification of at-risk children – before chronic disease develops
• Reduced clinician workload – especially in busy hospitals
• Fewer unnecessary prescriptions and emergency hospitalizations
• A simple, transparent, and fair clinical tool
• A framework for ethical, interpretable AI in pediatric medicine

Acknowledgment
We extend our deepest gratitude to Oman National University for making this important project possible through their trust and support. We also thank all our research collaborators, statistical advisors, and the entire Hekma Smart Solutions team for their hard work in preparing this successful grant proposal.

🔗 Get Involved
If you are a researcher, pediatrician, investor, or AI health enthusiast and would like to collaborate with us on this journey:
📧 Send us an email
🌐 Visit the Hekma Smart Solutions website
📄 The full research protocol and future publications will be shared soon.

Together, we will build a future where fewer children suffer from asthma.
Hekma Smart Solutions – AI for a better, healthier life.

“Grant Writing and Application” – A Comprehensive Guide to Securing International Research Funding

Hekma Smart Solutions is proud to announce the publication of the essential guide, “Grant Writing and Application.” This comprehensive book, developed with the financial support and strategic backing of both companies, serves as a definitive roadmap for researchers seeking to navigate the complex landscape of international research funding.

About the Book

Written in English by Dr. Gholamreza Habibi and Dr. Omid Kohandel — two distinguished experts with extensive experience in designing research projects, securing competitive grants, and authoring numerous scientific papers and books — this volume translates years of real-world expertise into an actionable framework.

Released in May 2026, the 150-page work is organized into 18 chapters and focuses specifically on the skills required to win prestigious global grants.

Core Objective & Target Audience

The book is designed to empower researchers, university faculty, and graduate students in their pursuit of international research funding. It provides a practical, step-by-step roadmap for grant applicants.

The primary audience is medical and biomedical researchers aiming to secure funding from leading international institutions, including:

– The National Institutes of Health (NIH) – USA

– Horizon Europe – European Union

– The Bill & Melinda Gates Foundation

– The World Health Organization (WHO)

– Other major academic associations and research centers

Key Message from the Authors

In the book’s introduction, the authors emphasize a critical shift in perspective:

“Securing an international grant no longer depends solely on ‘a good idea.’ It is now tied to the skill of scientific storytelling and a correct understanding of reviewer expectations. This book attempts to bridge that skills gap for researchers.”

Book Structure & Chapter Highlights

With a special focus on winning international grants, the book covers the entire lifecycle of a grant — from fundamentals to post-award management. Key sections include:

– Chapters 1–3: Fundamentals, terminology, a 12–18 month acquisition roadmap, and an in-depth look at government & intergovernmental grants (NIH, WHO, Horizon Europe).

– Chapters 4–5: Prominent non-profit foundations (Wellcome Trust, Gates Foundation) and private/industry grants from pharmaceutical and medical device companies (Pfizer, Roche, Johnson & Johnson).

– Chapters 6–9: Practical proposal writing techniques, budgeting, supporting documents (CVs, recommendation letters), and ethical & copyright considerations.

– Chapters 10–12: The peer review process, how to respond to reviewers after rejection or acceptance, and contract management & reporting after award.

– Chapters 13–17: Special strategies for researchers in developing countries, real-world case studies (successful and unsuccessful proposals), and a dedicated analysis of the research funding landscape in Oman and the GCC (Gulf Cooperation Council) region.

– Chapter 18: Concluding remarks and recommendations for continuous improvement.

Book Specifications

Format: Square / Block cut

Pages: 150

Chapters: 18

Special Features: Includes process diagrams, comparative tables, practical checklists, and real-world analyses of successful proposals (e.g., NIH & Gates Foundation).

Support and Acknowledgement

This publication was made possible through the financial and logistical support of Novarea Inc. and Hekma Smart Solutions — both committed to advancing research capacity and scientific excellence on an international scale.

For more information, review copies, or distribution inquiries, please contact the publishers or the supporting companies through their official websites.

Hekma Smart Solutions Wishes You a Bright & Innovative 2026

As we step into the new year, Hekma Smart Solutions extends our warmest congratulations for a prosperous and groundbreaking 2026.

May this year be marked by smart achievements, shared growth, and transformative successes. We look forward to building a more connected and intelligent future together.

Happy New Year 2026!

From all of us at Hekma Smart Solutions

55th Oman National Day

On behalf of Hekma Smart Solution, we extend our heartfelt congratulations to His Majesty Sultan Haitham bin Tariq and to the people of the Sultanate of Oman on the joyous occasion of the 55th National Day.

This special day is a celebration of Oman’s remarkable progress, its rich heritage, and its inspiring vision for a future built on innovation, unity, and prosperity. As a company committed to advancing digital health and AI-driven solutions, we are proud to support Oman’s digital transformation by developing smart platforms that enhance patient care, optimize healthcare workflows, and empower data-driven decision-making in line with Oman Vision 2040. We remain dedicated to building local capacity in AI, collaborating with clinicians, researchers, and institutions to bring cutting-edge technologies into everyday practice.

May this National Day bring renewed pride, strength, and success to the nation.
We look forward to continuing our collaboration with Omani institutions and supporting the country’s forward-looking ambitions in healthcare, technology, and human development.

With our warmest regards,
Hekma Smart Solution

We’re Proud to Announce Our PLOS One Publication: Evaluating OpenBioLLM’s Diagnostic Performance in Neurology

We are delighted to announce the publication of our latest research article, “Evaluating the diagnostic performance of OpenBioLLM in neurology: A case-based assessment of a medical large language model”, in the internationally recognized PLOS One journal (Impact Factor: 2.6, Q1 in Multidisciplinary Science).

Why is this article significant?

Artificial intelligence continues to reshape clinical decision-making, yet its real-world diagnostic accuracy remains under scrutiny. This study evaluates how a specialized medical large language model, OpenBioLLM, performs in diagnosing complex neurology cases — one of the most cognitively demanding areas in medicine.

What does the article reveal?

• The findings demonstrate that OpenBioLLM shows:
• Strong reasoning ability and fluency in clinical dialogue
• Promising capacity in lesion localization
• Moderate accuracy in identifying underlying neurological causes, suggesting the need for integration with retrieval-based or hybrid models for enhanced diagnostic precision

These results highlight both the potential and current limitations of large language models in clinical neurology and pave the way for developing next-generation AI systems that combine reasoning with medical knowledge retrieval.

Toward the Future of AI-Enhanced Medicine

This publication represents another milestone in the ongoing mission of Novarea and its official representative, Hekma Smart Solutions, to advance AI in healthcare.

Our interdisciplinary team is currently working on adapting and improving such models through innovative frameworks like Retrieval-Augmented Generation (RAG) to enhance real-time diagnostic support and medical reasoning.

Collaborative Innovation Across Borders

This research effort reflects the collaborative vision of Novarea (Novarea AI) and its official representative, Hekma Smart Solutions (Oman), in building global partnerships that bridge academic research, clinical expertise, and AI innovation.

Together, we continue to pioneer projects that integrate medical intelligence, data ethics, and localized health technologies to empower the next generation of healthcare solutions.

Our Research Article Published in Digital Health Journal: Next Generation of Language Models and Synthetic Approaches in Medical AI

We are proud to announce the publication of our new research in the internationally renowned Digital Health journal. This study addresses one of the most advanced approaches in medical artificial intelligence, Retrieval-Augmented Generation (RAG).

Why is this article significant?

Despite the impressive capabilities of large language models like GPT in generating text, they face limitations in the novelty of information and the accuracy of scientific content. This study demonstrates that integrating external search modules with these models can significantly enhance the quality of responses in medical applications.

What does the article review?

The article provides a narrative review of research that utilized RAG technology to improve AI performance in the medical field. Key advantages of this approach include:  

  • Simultaneous access to the model’s memory and online medical information sources  
  • Reduction of model-generated hallucinations  
  • Enhanced accuracy and realism in responses to clinical questions and decision-making  

Beyond the Review: A Roadmap for Future Research

The article not only reviews existing research but also identifies research gaps and proposes avenues for designing more precise evaluation frameworks in future projects, including: 

  • The need for rigorous comparative testing  
  • Development of standardized sources for information extraction  
  • Deeper understanding of user interaction with systems  

Hekma Leads in Integrating Language Models with Localized RAG Systems.

Our AI team is currently working on developing healthcare AI systems based on this framework, such as symptom-diagnosing chat bots, health education tools, and medical decision-support systems. This article serves as a scientific document for one of these emerging projects.

Toward a Smarter Future in Digital Health

Pur AI team, comprising over 100 specialists in medical and technical fields, is working on designing the next generation of AI tools to transform the healthcare system, from specialized chat bots and deep learning platforms to disease prediction models and smart patient management systems.

In addition to publishing in prestigious scientific journals, Hekma adopts a pioneering approach to commercializing its innovative products and has established extensive partnerships with Canadian based Novarea Inc. and also universities, research centers, practicing physicians, and local and international business incubators.

Strategic Partnership between Hekma Smart Solutions (Oman) and DigiMedica (Australia)

Hekma Smart Solutions is proud to announce the signing of a Memorandum of Understanding (MoU) with DigiMedica Pty Ltd, a healthtech company based in Australia. This collaboration marks a significant step toward cooperation of these two companies at the intersection of Artificial Intelligence (AI) and Digital Health.

The agreement outlines a wide range of joint activities across research, education, product development, commercialization, and strategic consulting.

Key Areas of Collaboration:

  • Research & Development in AI-powered healthcare projects
  • Design and development of joint digital health products
  • Educational programs including webinars, workshops, and training sessions
  • Consulting services for healthcare organizations in AI and digital health
  • Market expansion across the Gulf region and Australian markets
  • Joint development of an AI-based diabetes management platform

Dr Gholamreza Habibi, CEO of Hekma, stated:

“With our regional expertise and DigiMedica’s specialized capabilities in AI-driven health innovation in Australia, this partnership empowers us to co-create intelligent healthcare solutions that are scalable and impactful.”

DigiMedica Pty Ltd is an Australian health-tech company focused on advancing digital health and AI-driven healthcare innovations, delivering impactful solutions within the Australian market.

Hekma Smart Solutions is an Omani company specializing in innovative AI and digital health solutions, dedicated to addressing regional healthcare challenges with cutting-edge technology. Hekma is exclusive representative of Canadian based company – NOVAREA Inc.

For further information about the partnership and opportunities for collaboration, please reach out to Hekma’s Public Relations team.

Novarea Inc. (Canadian firm) and Hekma Smart Solutions (Omani firm) Forge Strategic Partnership to Boost Healthcare and Tech Innovation

Novarea Inc., a leading Canadian company specializing in AI and health technology, has signed a groundbreaking cooperation agreement with Oman’s Hekma Smart Solutions to enhance research, technology transfer, and AI-driven healthcare services in the Gulf Cooperation Council (GCC) region.

A Vision for Growth and Innovation

“This partnership marks a significant step in strengthening ties between Oman and Canada in healthcare and technology,” said Dr Gholamreza Habibi, CEO of Hekma Smart Solutions. “By combining our expertise with Hekma’s regional insights, we aim to drive innovation and improve healthcare outcomes in the GCC.” He added, “This collaboration aligns with Oman’s vision for a knowledge-based economy. We are excited to bring Novarea’s cutting-edge solutions to the region and empower local institutions with advanced research and AI capabilities.”

The agreement sets the stage for long-term cooperation, positioning both companies as key players in the GCC’s evolving healthcare and technology landscape.

Key Areas of Cooperation

1. Clinical Research: Bridging Canada and the GCC

Novarea will facilitate clinical research collaborations between North American pharmaceutical companies, clinical research organizations (CROs), and Omani/GCC institutions. This initiative aims to expand clinical trial opportunities, foster knowledge exchange, and support drug development in the region.

2. Technology Transfer & Tech Product Marketing

Novarea will identify and introduce innovative tech products and companies to Oman and the broader GCC market, enabling technology transfer and commercialization of cutting-edge solutions.

3. Artificial Intelligence (AI) Services

Hekma Smart Solutions will act as Novarea’s official representative in AI, offering advanced services in:

  • Large Language Models (LLM)– AI-driven text analysis, chatbots, and content generation.
  • Image Processing– Medical imaging, object detection, and computer vision.
  • Speech Processing– Voice recognition, natural language processing (NLP), and AI-based transcription.
  • Predictive Analytics– Data modeling and decision-making support.
  • Robotic Process Automation (RPA)– Streamlining business operations with AI.

4. Digital Health Solutions

Leveraging Novarea’s expertise in digital health, the partnership will introduce advanced platforms, including:

  • Telemedicine & Online Consultations
  • Medical Evaluation & Smart Feedback Systems
  • Health Social Networks & Learning Management Systems (LMS)
  • Health Business Intelligence (BI) & Analytics
    Hekma will work with Omani academic medical centers to deploy these solutions.

5. Research Services for Academia

Under the license of Novarea – SciPath Canada, Hekma will offer specialized research services to Omani and GCC universities, research centers, and faculty members, supporting academic and clinical studies.

6. Management & Business Consultation

The two companies will collaborate on providing expert consultancy in:

  • Investment & Financing
  • Market & Product Development
  • Human Resource Strategies
  • Sustainable & Green Corporate Development